2013, № 12 (161)

1. Meerson F.Z., Tverdokhlib V.P., Nikonorov A.A., Filippov V.K., Frolov B.A. The role of suppression of cholesterol 7-hydroxylase activity of the liver in the development of atherogenic stress-induced dyslipoproteinemia. Kardiologiia. 1988;28(9):85-87.

2. Baillie-Hamilton PF. Chemical toxins: a hypothesis to explain the global obesity epidemic. J. Altern. Complement. Med. 2002; 8: 185-192

3. Gaenzer H., Marschang P., Sturm W., Neumayr G., Vogel W., Patsch J., Weiss G. Association between increased iron stores and impaired endothelial function in patients with hereditary hemochromatosis. J Am Coll Cardiol. 2002; 40(12):2189-94.

4. Graham R.M., Chua A.C., Carter K.W., Delima R.D., Johnstone D., Herbison C.E., Firth M.J., O'Leary R., Milward E.A., Olynyk J.K., Trinder D. Hepatic iron loading in mice increases cholesterol biosynthesis. Hepatology, 2010; 52(2):462-71.

5. Ohguchi S., Ichimiya H., Yagi A., Hayashi H., Sakamoto N. Copper-induced hypercholesterolemia of golden hamsters: enhanced synthesis of cholesterol in the liver. Gastroenterol Jpn. 1988; 23(6):629-32.

6. Valko M., Morris H., Kronin MTD: Metals, toxicity and oxidative stress. Curr Med Chem. 2005; 12(10):1161-1208

7. Yuan X.M., Li W. The iron hypothesis of atherosclerosis and its clinical impact. Ann Med. 2003; 35(8):578-91.

About this article